LOW DOSE INTERLEUKIN 2 EXPANDS PLASMABLASTS WITH A REGULATORY B CELL PHENOTYPE POST-MT

被引：0
|
作者：
O'Brien, James [1 ]
Case, Ayden [1 ]
Sriranjan, Rochelle [1 ]
Tuong, Zewen Kelvin [1 ]
Cheriyan, Joseph [1 ]
Clatworthy, Menna [1 ]
Mallat, Ziad [1 ]
Zhao, Tian [1 ]
机构：
[1] Univ Cambridge, Med, Cambridge, England
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG041
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic cell carcinoma progressing on interleukin-2 alone
    Lissoni, P
    Rovelli, F
    Baiocco, N
    Tangini, G
    Fumagalli, L
    ANTICANCER RESEARCH, 2001, 21 (1B) : 777 - 779
  • [42] Low dose interleukin-2 therapy for ischemic retinopathies: correcting the balance between regulatory T cells and effector T cells
    Deliyanti, Devy
    Yanfaunnas, Faisal Farras
    Joglekar, Amit
    Wilkinson-Berka, Jennifer L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [43] Expansion of Regulatory T cells using Low-dose Interleukin-2 Attenuates Hypertension in an Experimental Model of Autoimmune Disease
    Taylor, Erin B.
    Ryan, Michael J.
    FASEB JOURNAL, 2017, 31
  • [44] In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation
    Tahvildari, Maryam
    Omoto, Masahiro
    Chen, Yihe
    Emami-Naeini, Parisa
    Inomata, Takenori
    Dohlman, Thomas H.
    Kaye, Abigail E.
    Chauhan, Sunil K.
    Dana, Reza
    TRANSPLANTATION, 2016, 100 (03) : 525 - 532
  • [45] IMMUNOLOGICAL EFFECTS OF ALTERNATIVE WEEKLY INTERFERON-ALPHA-2B AND LOW-DOSE INTERLEUKIN-2 IN PATIENTS WITH CANCER
    FIORENTINO, B
    DISTEFANO, P
    GIULIANI, C
    AMATETTI, C
    TINARI, N
    NATOLI, C
    GARUFI, C
    IACOBELLI, S
    BRITISH JOURNAL OF CANCER, 1992, 66 (05) : 981 - 983
  • [46] LOW-DOSE IL-2 THERAPY SELECTIVELY EXPANDS REGULATORY T CELLS AND AMELIORATES ESTABLISHED DISEASE IN (NZBxNZW) F1 LUPUS MICE
    Humrich, Jens Y.
    Kloke, Lutz
    Rose, Angelika
    von Spee, Caroline
    Klaus, Anika
    Riemekasten, Gabriela
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A67 - A67
  • [47] Low-dose interleukin-2 treatment increases the proportion of regulatory T cells in patients with rheumatic diseases: A meta-analysis
    Yan, Huanhuan
    Yan, Huer
    Liu, Lu
    Su, Rui
    Gao, Chong
    Li, Xiaofeng
    Wang, Caihong
    AUTOIMMUNITY REVIEWS, 2023, 22 (03)
  • [48] DIFFERENTIAL INHIBITION OF INTERLEUKIN 2-MEDIATED AND INTERLEUKIN 4-MEDIATED HUMAN B-CELL PROLIFERATION BY IONOMYCIN - A POSSIBLE REGULATORY ROLE FOR APOPTOSIS
    VAZQUEZ, A
    AUFFREDOU, MT
    CHAOUCHI, N
    TAIEB, J
    SHARMA, S
    GALANAUD, P
    LECA, G
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (10) : 2311 - 2316
  • [49] Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus
    Taylor, Erin B.
    Sasser, Jennifer M.
    Maeda, Kenji J.
    Ryan, Michael J.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (05) : F1274 - F1284
  • [50] Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2
    Correale, P
    Marsili, S
    Sabatino, M
    Montagnani, F
    Giorgi, G
    Francini, G
    ONCOLOGY REPORTS, 2005, 13 (04) : 751 - 756
12345